1. Ferulic acid interventions ameliorate NDEA-CCl4-induced hepatocellular carcinoma via Nrf2 and p53 upregulation and Akt/PKB-NF-κB-TNF-α pathway downregulation in male Wistar rats
- Author
-
Oluwatobi T. Somade, Babajide O. Ajayi, Olubisi E. Adeyi, Temitope A. Dada, Mukodaz A. Ayofe, David C. Inalu, Opeyemi I. Ajiboye, Olaoluwawunmi M. Shonoiki, Aminat O. Adelabu, Rasaq T. Onikola, Ismaila D. Isiaka, Opeyemi Omotoso, Adewale S. James, Tunde O. Olaniyan, Ayodeji M. Adegoke, Adio J. Akamo, Babatunji E. Oyinloye, and Ezekiel Adewole
- Subjects
Hepatocellular carcinoma ,DEN ,Ferulic acid ,P53 ,Nrf2 ,Akt ,Toxicology. Poisons ,RA1190-1270 - Abstract
Hepatocellular carcinoma is a prevalent form of liver cancer that is life threatening. Many chemically synthesized anti-cancer drugs have various degrees of side effects. Hence, this study investigated the effect of FEAC interventions on NDEA-CCl4-induced HCAR in male Wistar rats. HCAR was induced by intraperitoneal administration of 200 mg/kg of NDEA and 0.5 mL/kg CCl4 (as a promoter of HCAR). Following the induction of HCAR, rats were treated differently with two different doses (25 and 50 mg/kg) of FEAC. HCAR induction was confirmed by the significant elevation of serum levels of ALT, AST, and α-FP. Also elevated significantly were liver levels of Akt/PKB, NF-κB, TNF-α, MDA, GSH, and activities of GST, SOD, and CAT, while levels of liver p53 and Nrf2 were significantly lowered compared with normal rats. Treatment interventions with both 25 and 50 mg/kg of FEAC against the DEN-CCl4-induced HCAR gave comparable effects, marked by a significant reduction in the levels of serum ALT, AST and α-FP, as well as liver levels of MDA, GSH, Akt/PKB, NF-κB, TNF-α, GST, SOD, and CAT, while levels of liver p53 and Nrf2 were significantly elevated compared with normal rats. Put together and judging by the outcomes of this study, FEAC being a potent antioxidant may also be potent against chemical-induced HCAR via upregulation of p53 and Nrf2, as well as downregulation of the Akt/PKB-NF-κB pathway in rats.
- Published
- 2024
- Full Text
- View/download PDF